drugset
drugset / Trial / NCT00002964

Porfimer Sodium in Diagnosing Patients With Head and Neck Cancer

NCT00002964 ↗

Phase 2 Completed Roswell Park Cancer Institute
Diagnostic

Summary

RATIONALE: Drugs that make cancer cells more visible to light may help in the diagnosis of head and neck cancer. PURPOSE: Phase II trial to study the usefulness of porfimer sodium in diagnosing patients with head and neck cancer.

Timeline

Start
1995-02
Primary completion
2004-04
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject porfimer sodium Small molecule — Intravenous

Indications

head and neck cancer